Habib Bennaceur: Driving Haemoglobinopathies Progress Across Multiple Clinical Programmes At EHA 2026
Habib Bennaceur, Senior Vice President, Rare Disease at Novo Nordisk, shared a post on LinkedIn:
“As we return from Stockholm following the European Hematology Association Congress, I am struck by the energy, scientific exchange and sense of shared purpose across the haematology community.
For Novo Nordisk, EHA 2026 was an important opportunity to show the breadth of our long-term commitment to haemoglobinopathies – sharing progress across multiple clinical programmes, spanning all ages, and engaging with experts, advocates, and partners on what it will take to keep driving change for people affected by these diseases.
One theme really resonated for our team throughout the congress: scientific progress must remain grounded in the reality of people’s lives. That is why insights from our LISTEN survey are so important.
Based on experiences from more than 1,000 people across 17 countries, the findings help reframe our understanding of sickle cell disease from an episodic condition to a chronic, progressive and life-threatening one – with a daily burden that extends far beyond acute crises to ongoing fatigue, pain and toll of living with a disease that does not pause.
With World Sickle Cell Day approaching at the end of this week, I am encouraged by the progress being made – and even more determined to ensure that listening to the SCD community continues to guide the science, partnerships and action needed to improve lives.
Thank you to our Rare Disease team for your dedication and to everyone who connected with us in Stockholm!”
Stay updated with Hemostasis Today.
-
Sep 21, 2026, 20:56George Touma: ApoB Should Be Central to All Lipid Guidlines
-
Sep 21, 2026, 20:55Christopher Robinson: Obstetric Risks Are Seen at the Extremes of Birthweight
-
Sep 21, 2026, 20:54Emicizumab for Refractory GI Bleeding in Myeloma-Associated Acquired VWD – JTH
-
Sep 21, 2026, 20:52Ross Baker: ASH 2026 Guidelines on Iron Deficiency in HMB and Bleeding Disorders
-
Sep 21, 2026, 20:50Rainer Kaiser: Genes and Signalling Pathways Implicated in Procoagulant Platelet Generation
-
Sep 21, 2026, 20:49Natalia Dovlatova: Celebrating Stan Heptinstall and His Legacy in Platelet Science
-
Sep 21, 2026, 20:48Norm Roulet: The Interaction of Pb and SARS-CoV-2 and Its Impact on the Cardiovascular System
-
Sep 21, 2026, 20:45Felix Scholkmann: The Spleen Plays a Key Role in Regulating Platelet Activity
-
Sep 21, 2026, 20:43Claire Pomeroy: Celebrating the 2026 Lasker Awards and Why Medical Research Matters